The Association between the Lupus Anticoagulant and Cerebral Infarction in Systemic Lupus Erythematosus

References

• Bilaniuk L. T., Patel S., Zimmerman R. A. Computed tomography of sytemic lupus erythematosus. Radiology 1977; 124: 119
   PubMed Web of Science ®Google Scholar
• Carreras L. O., Vermijlen J. G. Lupus anticoagulant and thrombosis: possible role of inhibition of prostacyclin formation. Thromb Haemost 1982; 48: 38
   PubMed Web of Science ®Google Scholar
• Castellarnau C., Vila L., Sancho M. J., Borrell M., Fontcuberta J., Rutllant M. L. Lupus anticoagulant, recurrent abortion, and psotacyclin production by cultured smooth muscle cells. Lancet 1983; ii: 1137
   Google Scholar
• Conley C. L., Hartmann R. C. A haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621
   Web of Science ®Google Scholar
• Cosgriff T. M., Martin B. A. Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthritis Rheum 1981; 24: 94
   PubMed Web of Science ®Google Scholar
• Editorial. Lupus anticoagulant. Lancet 1984; i: 1157
   Google Scholar
• Elias M., Eldor A. Thromboembolism in patients with the “lupus”-type circulating anticoagulant. Arch Intern Med 1984; 144: 510
   PubMedGoogle Scholar
• Ellis S. G., Verity M. A. Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 1979; 8: 212
   PubMed Web of Science ®Google Scholar
• Filip D. J., Eckstein J. D., Veltkamp J. J. Hereditary antithrombin III deficiency and thromboembolic disease. Am J Hematol 1976; 2: 343
   Google Scholar
• Grigor R., Edmonds J., Lewkonia R., Bresnihan W., Hughes G. R. V. Systemic lupus erythematosus. A prospective study. Ann Rheum Dis 1978; 37: 121
   PubMed Web of Science ®Google Scholar
• Harris E. N., Gharavi A. E., Asherson R. A., Boey M. L., Hughes G. R. V. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheum 1984; 2: 47–51
   PubMedGoogle Scholar
• Hart R. G., Miller V. T., Coull B. M., Bril V. Cerebral infarction associated with lupus anticoagulants—preliminary report. Stroke 1984; 15: 114
   PubMed Web of Science ®Google Scholar
• Hughes G. R. V. Central nervous system lupus. Diagnosis and treatment. J Rheumatology 1980; 7: 405
   PubMed Web of Science ®Google Scholar
• Johnson R., Richardson E. The neurological manifestations of systemic lupus erythematosus. Medicine 1968; 47: 337
   PubMed Web of Science ®Google Scholar
• Kelley R. E., Gilman P. B., Kovacs A. G. Cerebral ischemia in the presence of lupus antiocagulant. Arch Neurol 1984; 41: 521
   PubMedGoogle Scholar
• Landi G., Calloni M., Sabbadini M. G., Mannucci P. M., Candelise L. Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983; 14: 377
   PubMed Web of Science ®Google Scholar
• Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983; i: 1461
   Google Scholar
• Mueh J. R., Herbst K. D., Rapaport S. I. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980; 92: 156
   PubMed Web of Science ®Google Scholar
• Paterson A., Timperley W., Slater D. Coagulation abnormalities in fatal cerebral lupus erythematosus. J R Soc Med 1981; 47: 53
   Google Scholar
• Pinching A. J., Travers R. L., Hughes G. R. V., Jones T., Moss S. Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet 1978; i: 898
   Google Scholar
• Sanfelippo M. J., Drayna C. J. Prekallikrein inhibition associated with the lupus anticoagulant—a mechanism of thrombosis. Am J Clin Pathol 1982; 77: 275
   PubMed Web of Science ®Google Scholar
• Schleider M. A., Nachman R. L., Jaffe E. A., Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499
   PubMed Web of Science ®Google Scholar
• Shapiro S. S., Thiagarajan P. Lupus anticoagulants. Prog Hemost Thromb 1982; 6: 263
   PubMedGoogle Scholar
• Tan E. M., Cohen A. S., Fries J. F., et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271
   PubMed Web of Science ®Google Scholar
• Thiagarajan P., Shapiro S. S., De Marco L. Monoclonal immunoglobulin in MX coagulation inhibitor with phospholipid specificity. J Clin Invest 1980; 66: 397
   PubMed Web of Science ®Google Scholar
• Waddell C. C., Brown J. A. The lupus anticoagulant in 14 male patients. JAMA 1982; 248: 2493
   PubMed Web of Science ®Google Scholar